Security key
03969F109
Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 50,826,972
- Total 13F value
- $2,056,609,533
- Share change
- +2,556,759
- Put/Call ratio
- 160%
- SEC-reported price per share
- $40.47
- Number of holders
- 136
- Value change
- +$107,109,155
- Number of buys
- 72
- Number of sells
- 65
- Shares outstanding
- 122,470,452
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
136
Top holders
10
RCUS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Arcus Biosciences, Inc. SEC filings
Arcus Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969F109
Recent filing periods:
Ownership snapshot
Top reported holders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EcoR1 Capital, LLC
Disclosed value leader
EcoR1 Capital, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 4.2%
Showing 1-6 of 15 holder rows.
Quick read
EcoR1 Capital, LLC leads the comparable SEC ownership view at 4.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EcoR1 Capital, LLC's linked filing trail.
Comparable ownership
Top 5
EcoR1 Capital, LLC
4.2%
BlackRock Finance, Inc.
3.4%
Alphabet Inc.
3.3%
PFM Health Sciences, LP
2.8%
BVF INC/IL
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC |
13F
Company
|
4.2%
|
$178,617,000
5,122,359 shares
|
— | 30 Sep 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
3.4%
|
$146,558,000
4,202,960 shares
|
— | 30 Sep 2021 |
| Alphabet Inc. |
13F
Company
|
3.3%
|
$142,984,000
4,100,475 shares
|
— | 30 Sep 2021 |
| PFM Health Sciences, LP |
13F
Company
|
2.8%
|
$119,639,000
3,431,010 shares
|
— | 30 Sep 2021 |
| BVF INC/IL |
13F
Company
|
2.6%
|
$112,624,000
3,229,822 shares
|
— | 30 Sep 2021 |
| FMR LLC |
13F
Company
|
2.5%
|
$107,789,000
3,091,165 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
136
Shares
50,826,972
Rows available
136
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
127
Q4 2021 holders
136
Holder diff
9
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend